Ad hoc: Evotec and Celgene enter into strategic oncology partnership




  • Evotec AG announced today that Evotec and Celgene Corporation have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/ad-hoc-releases/p/ad-hoc-evotec-and-celgene-enter-into-strategic-oncology-partnership-5685

    Du magst vielleicht auch